Morgan’s Stocks 2026: Halftime Review Hits Key Lanes
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
In 2024, comparing Itot and Vti costs helps identify the more economical choice for long-term retirement goals.
28,280 articlesAt midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
Oracle's shares have fallen steeply as AI hype cooled. This article breaks down whether the stock is a value opportun...
A private AI-focused fund has surged 1,200% on hype around Anthropic and SpaceX, drawing investor demand but also gro...
Peloton pivots to the commercial gym market with a new Commercial Series, sending shares higher as it targets gym cha...
When shares slip, income-minded investors can find rare opportunities. This guide spotlights three magnificent divide...
SpaceX headlines grab attention, but smart investors look for durable earnings growth in established aerospace player...
Hydrogen policy momentum and rising costs are shaping a wide range of outcomes for plug power (plug) stock, with anal...
Asana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
Alphabet reportedly priced a rare 100-year bond to back AI and data-center expansion, a move that stirs debate on lon...
If you’re hunting for a lifelong holding, the dividend track record of Medtronic is hard to ignore. This piece explai...
The SEC submitted interpretive guidance to OIRA to clarify how federal securities laws could apply to crypto assets. ...